You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease

    SBC: Metselex, Incorporated            Topic: 105

    ABSTRACT This Phase STTR Phase II proposal aims to engineer and scale-up a synthetic metabolic pathway in a microbial host to produce UDCA and related compounds. Additionally, the UDCA produced from the engineered synthetic metabolic pathway will be used to synthesize derivatives for testing in our Alzheimer’s Disease cell and animal models. The proposed work has high intellectual merit for the ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  2. 2-HOBA for Treatment of Pulmonary Hypertension

    SBC: MTI Biotech Incorporated            Topic: NHLBI

    PROJECT SUMMARY Although the ubiquity of metabolic problems in pulmonary hypertension (PH) has been known for more than a decade, a wealth of new details on the nature of this problem presents the opportunity for intervention. A combination of experimental work in cells and animals and early trials in humans, suggests that these metabolic problems are part of the causation for PH, and that inactiv ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. HIDEHO: HIerarchical DistributEd Heterogenous Optimization

    SBC: SMART INFORMATION FLOW TECHNOLOGIES LLC            Topic: AF21BT001

    Large-scale military and civilian planning problems are (1) distributed – decision-making is spread across multiple organizations, including organizations that must employ information that they are unable or unwilling to share; (2) heterogeneous – the domains of optimization and local criteria for optimality differ – and (3) hierarchical – higher levels of authority solve abstract versions ...

    STTR Phase II 2023 Department of DefenseAir Force
  4. Gaussian-Pareto Overbounding for Verification and Validation of Safety-Critical eVTOL and UAM Operations

    SBC: ASTER LABS, INC.            Topic: AFX20DTCSO1

    A Gaussian-Pareto Overbounding (GPO) software toolset will be developed for the verification and validation (V&V) of safety-critical Unmanned Aerial Systems (UAS). In particular, this includes the V&V of sensors used to operate UAS, including navigation systems, the Air Data System (ADS), the Power Monitoring System (PMS), and Collision Avoidance Systems (CAS). The model-based techniques offered i ...

    STTR Phase II 2022 Department of DefenseAir Force
  5. Care Assistant for Family Caregivers of Persons with Dementia During Out of the Home Activities

    SBC: Koronis Biomedical Technologies Corp.            Topic: R

    Abstract Increases in life expectancy together with demographic trends have fueled a rapid increase in America’s elderly population. As the number of older Americans has grown, so has the prevalence of aging-associated diseases, including Alzheimer’s Disease (AD) and other related dementias (ADRD). An estimated 5.4 Million Americans had AD in 2012, and that number is expected to double by 2030 ...

    STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  6. Cognitive Behavioral Therapy for Combat Related PTSD

    SBC: NIGHTWARE, INC            Topic: AF21BTCSO1

    Approximately 4% of the population, and 7% of combat veterans have nightmare disorder. Chronic nightmares are found in approximately 18% of patients with insomnia, 15% with anxiety and depression, and 50-80% of patients with PTSD. Annually, eight (8) Million Americans and 20% of Airmen and Soldiers serving in wartime operations and US conflicts are diagnosed with Post Traumatic Stress Disorder (PT ...

    STTR Phase II 2022 Department of DefenseAir Force
  7. Secure Document Generation

    SBC: Inkit Inc.            Topic: AF21BTCSO1

    The issues in the Afghan evacuation highlight the Air Force is lacking in its capability to collect, compile, and disseminate data reports in a timely manner. The Air Force can only move as fast as its ability to disseminate information and make informed

    STTR Phase II 2022 Department of DefenseAir Force
  8. 3D Printed Multifunctional Brain Windows for Simultaneous Optical Imaging and Electrophysiology

    SBC: APPLIED UNIVERSAL DYNAMICS, CORP            Topic: 102

    PROJECT SUMMARY This proposal responds to PAR-18-870 titled “BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR).” This project is a Fast Track STTR with a phase I and phase II. The small business, Applied Universal Dynamics Corp. (AUD) is collaborating with the University of Minnesota (U of MN). The activity patterns of t ...

    STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  9. Inkit- Predictive Supply Chain

    SBC: Inkit Inc.            Topic: AF20CTCSO1

    Inkit’s Reach Enablement Platform (REP) will save the Air Force millions of dollars through the streamlined process for spare part sourcing and ordering. Inkit’s software product suite enables end-users (in this instance, maintainers and CE personnel) to place automated digital orders to a network of configurable 3rd-party vendors. Not only does it allow efficiency regarding end-user and vendo ...

    STTR Phase II 2021 Department of DefenseAir Force
  10. Development of a treatment for the durable remission of HIV using autologous human CAR T cells that target B cell follicles

    SBC: MARPAM PHARMA LLC            Topic: NIAID

    ABSTRACT MarPam Pharma is developing a one-time treatment for durable remission of human immunodeficiency virus (HIV) for patients treated with antiretroviral therapy (ART). This treatment is an autologous HIV-specific chimeric antigen receptor (CAR; specifically, CD4-MBL-CAR) T cell therapy that employs the CXCR5 chemokine receptor as a homing device to direct anti-HIV killer T cells into “hidd ...

    STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government